Clinical Trials Directory

Trials / Unknown

UnknownNCT02868814

The Efficacy and Safety of Pregabalin Release Tablets for the Treatment of Fibromyalgia

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
240 (estimated)
Sponsor
Jiangsu HengRui Medicine Co., Ltd. · Industry
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the Efficacy and safety of pregabalin sustained release tablets versus placebo for fibromyalgia

Conditions

Interventions

TypeNameDescription
DRUGPregabalin Release Tablets
DRUGPregabalin Release Tablets
DRUGPlacebo

Timeline

Start date
2016-05-01
Primary completion
2019-05-01
Completion
2019-05-01
First posted
2016-08-16
Last updated
2016-08-16

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02868814. Inclusion in this directory is not an endorsement.

The Efficacy and Safety of Pregabalin Release Tablets for the Treatment of Fibromyalgia (NCT02868814) · Clinical Trials Directory